Cutting Oral JAK 1/2 Inhibitor Dose an Option in RA (CME/CE)

(MedPage Today) -- Baricitinib dose reduction successful in patients with sustained disease control
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care